Matthew Macaluso

1.5k total citations
64 papers, 902 citations indexed

About

Matthew Macaluso is a scholar working on Pharmacology, Biological Psychiatry and Psychiatry and Mental health. According to data from OpenAlex, Matthew Macaluso has authored 64 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 15 papers in Biological Psychiatry and 15 papers in Psychiatry and Mental health. Recurrent topics in Matthew Macaluso's work include Treatment of Major Depression (21 papers), Tryptophan and brain disorders (15 papers) and Pharmacogenetics and Drug Metabolism (10 papers). Matthew Macaluso is often cited by papers focused on Treatment of Major Depression (21 papers), Tryptophan and brain disorders (15 papers) and Pharmacogenetics and Drug Metabolism (10 papers). Matthew Macaluso collaborates with scholars based in United States, Australia and Canada. Matthew Macaluso's co-authors include Sheldon Preskorn, Gary Zammit, Ronald M. Burch, Joseph R. Moskal, Tiffany Schwasinger‐Schmidt, Michael E. Thase, Brent P. Forester, Anthony J. Rothschild, Charles DeBattista and Boadie W. Dunlop and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLANT PHYSIOLOGY.

In The Last Decade

Matthew Macaluso

59 papers receiving 872 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Macaluso United States 14 372 239 209 203 142 64 902
Christine J. Guico‐Pabia United States 21 625 1.7× 165 0.7× 263 1.3× 181 0.9× 81 0.6× 42 1.1k
Maureen S. Drews United States 10 294 0.8× 171 0.7× 227 1.1× 343 1.7× 38 0.3× 11 765
Silvia Paddock United States 9 286 0.8× 211 0.9× 199 1.0× 70 0.3× 112 0.8× 17 826
Tatjana Dose Germany 7 196 0.5× 177 0.7× 174 0.8× 71 0.3× 69 0.5× 10 658
Karen Snyder United States 11 436 1.2× 178 0.7× 384 1.8× 371 1.8× 36 0.3× 12 885
Yuki Matsuda Japan 19 242 0.7× 152 0.6× 587 2.8× 73 0.4× 117 0.8× 77 1.2k
C.M.E. Kremer United States 13 651 1.8× 158 0.7× 569 2.7× 115 0.6× 112 0.8× 34 1.2k
Stefan Unterecker Germany 14 235 0.6× 66 0.3× 372 1.8× 93 0.5× 101 0.7× 71 818
Judith C. Kando United States 15 264 0.7× 94 0.4× 741 3.5× 133 0.7× 135 1.0× 40 1.2k
Massimo Carlo Mauri Italy 21 372 1.0× 296 1.2× 851 4.1× 86 0.4× 155 1.1× 60 1.5k

Countries citing papers authored by Matthew Macaluso

Since Specialization
Citations

This map shows the geographic impact of Matthew Macaluso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Macaluso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Macaluso more than expected).

Fields of papers citing papers by Matthew Macaluso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Macaluso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Macaluso. The network helps show where Matthew Macaluso may publish in the future.

Co-authorship network of co-authors of Matthew Macaluso

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Macaluso. A scholar is included among the top collaborators of Matthew Macaluso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Macaluso. Matthew Macaluso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olagunju, Andrew T, et al.. (2025). Racial and Ethnic Considerations for the Clinical Practice of Psychopharmacology and Research Methodology: A Narrative Review of the Growing Body of Literature. Journal of Psychiatric Practice. 31(2). 56–64. 2 indexed citations
2.
Macaluso, Matthew, Sheldon Preskorn, & Richard C. Shelton. (2023). Drug Development in Psychiatry. Advances in neurobiology. 1 indexed citations
3.
Kitay, Brandon M., Matthew Macaluso, Philip R. Corlett, et al.. (2023). Cognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: The CBT-ENDURE randomized clinical trial study protocol. Psychiatry Research. 330. 115585–115585. 4 indexed citations
4.
Kinzie, J. Mark, Sandra M. DeJong, Laura Edgar, et al.. (2021). Psychiatry Milestones 2.0: Using the Supplemental Guide to Create a Shared Model of the Development of Professional Identity and Expertise. Academic Psychiatry. 45(4). 500–505. 2 indexed citations
5.
Turkoz, Ibrahim, Ella Daly, Jaskaran Singh, et al.. (2021). Treatment Response With Esketamine Nasal Spray Plus an Oral Antidepressant in Patients With Treatment-Resistant Depression Without Evidence of Early Response. The Journal of Clinical Psychiatry. 82(4). 17 indexed citations
6.
Iovieno, Nadia, George I. Papakostas, Maurizio Fava, et al.. (2021). Vortioxetine Versus Placebo for Major Depressive Disorder. The Journal of Clinical Psychiatry. 82(4). 27 indexed citations
7.
DeJong, Sandra M., Adam M. Brenner, Matthew Macaluso, et al.. (2021). Challenges of Assessing Resident Competency in Well-Being: Development of the Psychiatry Milestones 2.0 Well-Being Subcompetency. Academic Medicine. 97(3). 351–356. 2 indexed citations
8.
Forester, Brent P., Sagar V. Parikh, Sara L. Weisenbach, et al.. (2020). Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression. American Journal of Geriatric Psychiatry. 28(9). 933–945. 16 indexed citations
9.
Dunlop, Boadie W., Sagar V. Parikh, Anthony J. Rothschild, et al.. (2019). Comparing sensitivity to change using the 6-item versus the 17-item Hamilton depression rating scale in the GUIDED randomized controlled trial. BMC Psychiatry. 19(1). 420–420. 22 indexed citations
10.
Schwasinger‐Schmidt, Tiffany & Matthew Macaluso. (2018). Other Antidepressants. Handbook of experimental pharmacology. 250. 325–355. 43 indexed citations
11.
Macaluso, Matthew, et al.. (2017). Tardive Dyskinesia: A Historical Perspective. Journal of Psychiatric Practice. 23(2). 121–129. 9 indexed citations
12.
Huprich, Steven K., Kevin B. Meehan, Caleb J. Siefert, et al.. (2017). Introduction of the DSM-5 levels of Personality Functioning Questionnaire.. Personality Disorders Theory Research and Treatment. 9(6). 553–563. 74 indexed citations
13.
Macaluso, Matthew, et al.. (2016). What Clinicians Need to Know about Treating Opioid Use Disorder: Choose Medication and Non-Medication Options to Fight Abuse and Relapse. Current psychiatry. 15(8). 20. 1 indexed citations
14.
15.
Macaluso, Matthew, et al.. (2013). Overcoming Medication Nonadherence in Schizophrenia: Strategies That Can Reduce Harm: Dosing Strategies, Direct Inquiry, Psychoeducation Can Improve Outcomes. Current psychiatry. 12(11). 14. 4 indexed citations
16.
Macaluso, Matthew, et al.. (2013). Antipsychotics for Nonpsychotic Illness: Limited Evidence Suggests Possible Efficacy Based on Known Receptor Binding Affinities. Current psychiatry. 12(2). 22. 1 indexed citations
17.
Macaluso, Matthew & Sheldon Preskorn. (2012). How Biomarkers Will Change Psychiatry. Journal of Psychiatric Practice. 18(2). 118–121. 21 indexed citations
18.
Khan, Ahsan Y., et al.. (2010). The Adjunctive Use of Metformin to Treat or Prevent Atypical Antipsychotic-Induced Weight Gain: A Review. Journal of Psychiatric Practice. 16(5). 289–296. 12 indexed citations
19.
Macaluso, Matthew, et al.. (2010). Twenty Percent of a Representative Sample of Patients Taking Bupropion Have Abnormal, Asymptomatic Electroencephalographic Findings. Journal of Clinical Psychopharmacology. 30(3). 312–317. 9 indexed citations
20.
Khan, Ahsan Y. & Matthew Macaluso. (2008). Duloxetine for the treatment of generalized anxiety disorder: a review. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine J. Guico‐Pabia Breakdown of academic impact, for papers by Maureen S. Drews Breakdown of academic impact, for papers by Silvia Paddock Breakdown of academic impact, for papers by Tatjana Dose Breakdown of academic impact, for papers by Karen Snyder Breakdown of academic impact, for papers by Yuki Matsuda Breakdown of academic impact, for papers by C.M.E. Kremer Breakdown of academic impact, for papers by Stefan Unterecker Breakdown of academic impact, for papers by Judith C. Kando Breakdown of academic impact, for papers by Massimo Carlo Mauri
Rankless by CCL
2026